Hanane Abbou | Biology | Research Excellence Award Published on 26/12/202526/12/2025 by Environmental Scientists Mrs. Hanane Abbou | Biology | Research Excellence Award Mrs. Hanane Abbou | Biology | PhD at Mohammed VI university of Sciences and Health | Morocco Mrs. Hanane Abbou is a science researcher and computational biologist whose work bridges bioinformatics, molecular modeling, and translational biomedical research, with a strong focus on drug discovery, infectious diseases, cancer biology, and toxinology. Mrs. Hanane Abbou is affiliated with Mohammed VI University of Sciences and Health and the Mohammed VI Center for Research and Innovation, where she contributes to interdisciplinary research that integrates theoretical biology with practical health applications. Mrs. Hanane Abbou received her academic training in life sciences with a specialization in computational and molecular biology, building a strong foundation in bioinformatics, structural biology, and in silico drug design, which has shaped her research-driven career. Citation Metrics (Google Scholar) 20 16 12 8 4 0 Citations 14 i10index 0 h-index 2 🟦 Citations 🟥 Documents 🟩 h-index View Google Scholar Profile Featured Publications: Selective Non-toxics Inhibitors Targeting DHFR for Tuberculosis and Cancer Therapy: Pharmacophore Generation and Molecular Dynamics Simulation – Bioinformatics and Biology Insights, 2023 · 5 Citations In Silico Analyses of All STAT3 Missense Variants Leading to Explore Divergent AD-HIES Clinical Phenotypes – Evolutionary Bioinformatics, 2023 · 5 Citations Staphylococcus hominis as a source of antimicrobial peptides: Identification of a new peptide with potential antimicrobial properties using in silico approach – Archives of Microbiology, 2025 · 2 Citations Virtual docking screening and quantitative structure-activity relationship studies to explore AKT and PI3K inhibitors acting on mTOR in cancers – Contemporary Oncology, 2023 · 2 Citations Computational immunology in venom research: A systematic review of epitope prediction and validation approaches – Briefings in Bioinformatics, 2025
Anam Farzand | Molecular Biology | Best Researcher Award Published on 14/11/202514/11/2025 by Environmental Scientists Ms. Anam Farzand | Molecular Biology | Best Researcher Award Sultan Zainal Abidin University | Malaysia Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).